Haisco Pharmaceutical Group Co., Ltd.
002653
Rank in Stocks
#2164
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Share Price
$8.28
Market Cap
$9.44B
Change (1 day)
0.60%
Change (1 year)
12.37%
Country
CN
Trade Haisco Pharmaceutical Group Co., Ltd. (002653)
Category
Healthcare
EPS for Haisco Pharmaceutical Group Co., Ltd. (002653)
EPS as of June 2026 TTM: $0.13
According to Haisco Pharmaceutical Group Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is $0.13. At the end of 2023 the company had a EPS of $0.04 equal to its 2022 EPS that were of $0.04.
EPS history for Haisco Pharmaceutical Group Co., Ltd. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.13 | 155.00% |
| 2024 | $0.05 | 27.03% |
| 2023 | $0.04 | 2.14% |
| 2022 | $0.04 | -25.99% |
| 2021 | $0.05 | -44.68% |
| 2020 | $0.09 | 37.82% |
| 2019 | $0.07 | 46.56% |
| 2018 | $0.05 | 33.43% |
| 2017 | $0.03 | -42.81% |
| 2016 | $0.06 | 9.65% |
| 2015 | $0.05 | -20.50% |
| 2014 | $0.07 | -14.29% |
| 2013 | $0.08 | 20.40% |
| 2012 | $0.07 | 29.33% |
| 2011 | $0.05 | 4.74% |
| 2010 | $0.05 | 6.83% |
| 2009 | $0.05 | 47.40% |
| 2008 | $0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $17.32 | 13,484.31% |
US
|
|
| $-7.98 | -6,358.82% |
US
|
|
| $-5.29 | -4,249.02% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 21,656.86% |
NL
|
